United States Phosphodiesterase V Inhibitors Market Report 2016

September 2016 | 123 pages | ID: U674F384D42EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Phosphodiesterase V Inhibitors

Revenue, means the sales value of Phosphodiesterase V Inhibitors

This report studies sales (consumption) of Phosphodiesterase V Inhibitors in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Actelion Pharmaceuticals Ltd.
• United Therapeutics Corporation
• Gilead sciences
• Bayer AG
• SteadyMed Ltd.
• GlaxoSmithKline plc
• Pfizer Inc.
• Reata Pharmaceuticals Inc.
• Arena Pharmaceuticals Inc.
• Merck & Co. Inc

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Phosphodiesterase V Inhibitors in each application, can be divided into

• Health care
• Clinic
• Hospital

Contents

United States Phosphodiesterase V Inhibitors Market Report 2016

1 PHOSPHODIESTERASE V INHIBITORS OVERVIEW

1.1 Product Overview and Scope of Phosphodiesterase V Inhibitors
1.2 Classification of Phosphodiesterase V Inhibitors
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Phosphodiesterase V Inhibitors
  1.3.1 Health care
  1.3.2 Clinic
  1.3.3 Hospital
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Phosphodiesterase V Inhibitors (2011-2021)
  1.4.1 USA Phosphodiesterase V Inhibitors Sales and Growth Rate (2011-2021)
  1.4.2 USA Phosphodiesterase V Inhibitors Revenue and Growth Rate (2011-2021)

2 USA PHOSPHODIESTERASE V INHIBITORS COMPETITION BY MANUFACTURERS

2.1 USA Phosphodiesterase V Inhibitors Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Phosphodiesterase V Inhibitors Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Phosphodiesterase V Inhibitors Average Price by Manufactures (2015 and 2016)
2.4 Phosphodiesterase V Inhibitors Market Competitive Situation and Trends
  2.4.1 Phosphodiesterase V Inhibitors Market Concentration Rate
  2.4.2 Phosphodiesterase V Inhibitors Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA PHOSPHODIESTERASE V INHIBITORS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Phosphodiesterase V Inhibitors Sales and Market Share by Type (2011-2016)
3.2 USA Phosphodiesterase V Inhibitors Revenue and Market Share by Type (2011-2016)
3.3 USA Phosphodiesterase V Inhibitors Price by Type (2011-2016)
3.4 USA Phosphodiesterase V Inhibitors Sales Growth Rate by Type (2011-2016)

4 USA PHOSPHODIESTERASE V INHIBITORS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Phosphodiesterase V Inhibitors Sales and Market Share by Application (2011-2016)
4.2 USA Phosphodiesterase V Inhibitors Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA PHOSPHODIESTERASE V INHIBITORS MANUFACTURERS PROFILES/ANALYSIS

5.1 Actelion Pharmaceuticals Ltd.
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Actelion Pharmaceuticals Ltd. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 United Therapeutics Corporation
  5.2.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 United Therapeutics Corporation Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Gilead sciences
  5.3.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Gilead sciences Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Bayer AG
  5.4.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Bayer AG Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 SteadyMed Ltd.
  5.5.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 SteadyMed Ltd. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 GlaxoSmithKline plc
  5.6.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 GlaxoSmithKline plc Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Pfizer Inc.
  5.7.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Pfizer Inc. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Reata Pharmaceuticals Inc.
  5.8.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Reata Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Arena Pharmaceuticals Inc.
  5.9.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Arena Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Merck & Co. Inc
  5.10.2 Phosphodiesterase V Inhibitors Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Merck & Co. Inc Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 PHOSPHODIESTERASE V INHIBITORS MANUFACTURING COST ANALYSIS

6.1 Phosphodiesterase V Inhibitors Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Phosphodiesterase V Inhibitors

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Phosphodiesterase V Inhibitors Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Phosphodiesterase V Inhibitors Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA PHOSPHODIESTERASE V INHIBITORS MARKET FORECAST (2016-2021)

10.1 USA Phosphodiesterase V Inhibitors Sales, Revenue Forecast (2016-2021)
10.2 USA Phosphodiesterase V Inhibitors Sales Forecast by Type (2016-2021)
10.3 USA Phosphodiesterase V Inhibitors Sales Forecast by Application (2016-2021)
10.4 Phosphodiesterase V Inhibitors Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Phosphodiesterase V Inhibitors
Table Classification of Phosphodiesterase V Inhibitors
Figure USA Sales Market Share of Phosphodiesterase V Inhibitors by Type in 2015
Table Application of Phosphodiesterase V Inhibitors
Figure USA Sales Market Share of Phosphodiesterase V Inhibitors by Application in 2015
Figure Health care Examples
Figure Clinic Examples
Figure Hospital Examples
Figure USA Phosphodiesterase V Inhibitors Sales and Growth Rate (2011-2021)
Figure USA Phosphodiesterase V Inhibitors Revenue and Growth Rate (2011-2021)
Table USA Phosphodiesterase V Inhibitors Sales of Key Manufacturers (2015 and 2016)
Table USA Phosphodiesterase V Inhibitors Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Phosphodiesterase V Inhibitors Sales Share by Manufacturers
Figure 2016 Phosphodiesterase V Inhibitors Sales Share by Manufacturers
Table USA Phosphodiesterase V Inhibitors Revenue by Manufacturers (2015 and 2016)
Table USA Phosphodiesterase V Inhibitors Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Phosphodiesterase V Inhibitors Revenue Share by Manufacturers
Table 2016 USA Phosphodiesterase V Inhibitors Revenue Share by Manufacturers
Table USA Market Phosphodiesterase V Inhibitors Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Phosphodiesterase V Inhibitors Average Price of Key Manufacturers in 2015
Figure Phosphodiesterase V Inhibitors Market Share of Top 3 Manufacturers
Figure Phosphodiesterase V Inhibitors Market Share of Top 5 Manufacturers
Table USA Phosphodiesterase V Inhibitors Sales by Type (2011-2016)
Table USA Phosphodiesterase V Inhibitors Sales Share by Type (2011-2016)
Figure USA Phosphodiesterase V Inhibitors Sales Market Share by Type in 2015
Table USA Phosphodiesterase V Inhibitors Revenue and Market Share by Type (2011-2016)
Table USA Phosphodiesterase V Inhibitors Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Phosphodiesterase V Inhibitors by Type (2011-2016)
Table USA Phosphodiesterase V Inhibitors Price by Type (2011-2016)
Figure USA Phosphodiesterase V Inhibitors Sales Growth Rate by Type (2011-2016)
Table USA Phosphodiesterase V Inhibitors Sales by Application (2011-2016)
Table USA Phosphodiesterase V Inhibitors Sales Market Share by Application (2011-2016)
Figure USA Phosphodiesterase V Inhibitors Sales Market Share by Application in 2015
Table USA Phosphodiesterase V Inhibitors Sales Growth Rate by Application (2011-2016)
Figure USA Phosphodiesterase V Inhibitors Sales Growth Rate by Application (2011-2016)
Table Actelion Pharmaceuticals Ltd. Basic Information List
Table Actelion Pharmaceuticals Ltd. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corporation Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table Gilead sciences Basic Information List
Table Gilead sciences Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead sciences Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table SteadyMed Ltd. Basic Information List
Table SteadyMed Ltd. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table SteadyMed Ltd. Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline plc Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table Reata Pharmaceuticals Inc. Basic Information List
Table Reata Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reata Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Inc. Basic Information List
Table Arena Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Inc. Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table Merck & Co. Inc Basic Information List
Table Merck & Co. Inc Phosphodiesterase V Inhibitors Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc Phosphodiesterase V Inhibitors Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Phosphodiesterase V Inhibitors
Figure Manufacturing Process Analysis of Phosphodiesterase V Inhibitors
Figure Phosphodiesterase V Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of Phosphodiesterase V Inhibitors Major Manufacturers in 2015
Table Major Buyers of Phosphodiesterase V Inhibitors
Table Distributors/Traders List
Figure USA Phosphodiesterase V Inhibitors Production and Growth Rate Forecast (2016-2021)
Figure USA Phosphodiesterase V Inhibitors Revenue and Growth Rate Forecast (2016-2021)
Table USA Phosphodiesterase V Inhibitors Production Forecast by Type (2016-2021)
Table USA Phosphodiesterase V Inhibitors Consumption Forecast by Application (2016-2021)